Illustrative packaging · Research use only
Metabolic & incretin
RT3
Choose a specification
1 pack · 10 vials total
Guest checkout is available. Create an account before your first request to receive the eligible 10% welcome offer.
Choose your payment method at checkout to see the total and next payment steps. No administration or personal-use guidance is provided.
Human phase 2 randomized trial
What the research examines
RT3 activates GIP, GLP-1 and glucagon receptors. A randomized trial in adults with obesity examined body-weight change and adverse events with a specifically manufactured investigational formulation. The findings concern multi-receptor metabolic signaling in that study population.
Potential research applications
Research questions include how combined receptor activation affects metabolic endpoints and how efficacy measurements relate to tolerability.
These are research questions drawn from the cited work, not established applications of this supplied material.
Evidence limits
The cited trial is clinical evidence for its investigational formulation, not analytical validation of this research material. It does not establish interchangeability with the study product.
Material identity and presentation
Powder vial artwork is conceptual; actual form and packaging unverified. Published findings do not establish the identity, purity or performance of an individual supplied material.
